.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,593,482

« Back to Dashboard

Details for Patent: 6,593,482

Title: Methods for preparing new taxoids and pharmaceutical compositions containing them
Abstract:Methods of preparing methylthiomethyloxy taxoids of formula (XXXIV) ##STR1## from baccatin and .beta.-lactam are presented. These new taxoids display noteworthy anti-tumor and anti-leukemic properties.
Inventor(s): Bouchard; Herve (Thiais, FR), Bourzat; Jean-Dominique (Vincennes, FR), Commer.cedilla.on; Alain (Vitry-sur-Seine, FR), Ojima; Iwao (Port Jefferson, NY)
Assignee: Aventis Pharma S.A. (Antony, FR) The Research Foundation of State University of New York (Albany, NY)
Filing Date:Dec 31, 2001
Application Number:10/029,954
Claims:1. A method of preparing (2R,3S)-3-benzoylamino-2-hydroxy-3-phenylpropionate of 4,10.beta.-diacetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1,13.alpha.-dihy droxy-7.beta.-methylthiomethyloxy-9-oxo-tax-11-ene, formula (XXXIV): ##STR36##

comprising: silylating a baccatin of formula (IX): ##STR37## to obtain a silylated baccatin, wherein the silylation occurs at position 7; acetylating said silylated baccatin to obtain a silylated baccatin III of formula (XXX): ##STR38## removing the silyl group to obtain baccatin III with a 7-hydroxy group; or, alternatively, directly acetylating the baccatin of formula (IX) to obtain baccatin III with a 7-hydroxy group; reacting said baccatin III with a 7-hydroxy group, wherein said reacting may include more than one reaction step, including an optional reduction reaction, to generate a compound of formula (A): ##STR39## wherein R is hydrogen; performing a metalation of said compound of formula (A) with an alkali metal or alkaline earth metal base, to produce a metalized methylthiomethyl-baccatin III derivative of formula (A), wherein R is an alkali metal or alkaline earth metal; coupling said metalized methylthiomethyl-baccatin III derivative of formula (A) with a protected .beta.-lactam, wherein said protected .beta.-lactam comprises a .beta.-lactam of formula: ##STR40## wherein Y is oxygen; G.sub.1 is an hydroxyl protecting group; R.sub.2 " is phenyl; and R.sub.3 " is phenyl; to produce a 2'-protected 7-methylthiomethyl-paclitaxel derivative; ##STR41## and deprotecting said 2'-protected 7-methylthiomethyl-paclitaxel derivative by removing G.sub.1 to produce a compound of formula (XXXIV).

2. The method according to claim 1, wherein said baccatin III with a 7-hydroxy group is subjected to Pummerer reaction conditions to obtain said compound of formula (A).

3. The method according to claim 1, wherein said baccatin III with a 7-hydroxy group is reacted with dimethyl sulfide and benzoyl peroxide to obtain said compound of formula (A).

4. The method according to claim 2, wherein the alkali metal or alkaline earth metal base is at least one compound selected from sodium hexamethyldisilazide (NaHMDS), potassium hexamethyldisilazide (KHMDS), lithium hexamethyldisilazide (LiHMDS), potassium diisopropylamide (KDA), lithium diisopropylamide (LDA), sodium hydride (NaH), potassium hydride (KH), lithium hydride (LiH), calcium hydride (CaH.sub.2), magnesium hydride (MgH.sub.2), and n-butyl Li.

5. The method according to claim 4, wherein said at least one compound is a hexamethyldisilazide.

6. The method according to claim 5, wherein said hexamethyldisilazide is sodium hexamethyldisilazide, and R is Na.

7. The method according to claim 6, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), TIPSO, tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

8. The method according to claim 7, wherein G.sub.1 is ethoxyethyl.

9. The method according to claim 5, wherein said hexamethyldisilazide is lithium hexamethyldisilazide, and R is Li.

10. The method according to claim 9, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

11. The method according to claim 10, wherein G.sub.1 is ethoxyethyl.

12. The method according to claim 3, wherein the alkali metal or alkaline earth metal base is at least one compound selected from sodium hexamethyldisilazide (NaHMDS), potassium hexamethyldisilazide (KHMDS), lithium hexamethyldisilazide (LiHMDS), potassium diisopropylamide (KDA), lithium diisopropylamide (LDA), sodium hydride (NaH), potassium hydride (KH), lithium hydride (LiH), calcium hydride (CaH.sub.2), magnesium hydride (MgH.sub.2), and n-butyl Li.

13. The method according to claim 12, wherein said at least one compound is a hexamethyldisilazide.

14. The method according to claim 13, wherein said hexamethyldisilazide is sodium hexamethyldisilazide, and R is Na.

15. The method according to claim 14, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

16. The method according to claim 15, wherein G.sub.1 is ethoxyethyl.

17. The method according to claim 13, wherein said hexamethyldisilazide is lithium hexamethyldisilazide, and R is Li.

18. The method according to claim 17, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

19. The method according to claim 18, wherein G.sub.1 is ethoxyethyl.

20. A method of preparing (2R,3S)-3-benzoylamino-2-hydroxy-3-phenylpropionate of 4,10.beta.-diacetoxy-2.alpha.-benzoyloxy-5.beta.,20-epoxy-1,13.alpha.-dihy droxy-7.beta.-methylthiomethyloxy-oxo-tax-11-ene, formula (XXXIV): ##STR42##

comprising: silylating a deacetylbaccatin III of formula (IX): ##STR43## to obtain a silylated deacetyl baccatin III derivative, wherein the silylation occurs at position 7; acetylating said silylated deacetyl baccatin Iii derivative to obtain a silylated baccatin III of formula (XXX): ##STR44## performing a metalation of said silylated baccatin III of formula (XXX) with an alkali metal or alkaline earth metal base to produce a metalized silylated baccatin III derivative, in which 13-hydroxy becomes 13-RO, where R is an alkali metal or alkaline earth metal; coupling said metalized silylated baccatin III derivative with a .beta.-lactam, wherein said .beta.-lactam comprises a lactam of formula: ##STR45## wherein Y is oxygen; G.sub.1 is an hydroxyl protecting group; R.sub.2 " is phenyl; and R.sub.3 " is phenyl; to generate a 2'-protected 7-silylated paclitaxel derivative; removing the 7-silyl group to obtain a 2'-protected paclitaxel derivative with a 7-hydroxy group; reacting said 2'-protected paclitaxel derivative with a 7-hydroxy group to obtain a 7-methylthiomethyl-paclitaxel derivative, wherein G.sub.1 is optionally replaced by H; and optionally deprotecting said 7-methylthiomethyl-paclitaxel derivative by removing G.sub.1 to produce a compound of formula (XXXIV).

21. The method according to claim 20, wherein said 2'-protected paclitaxel derivative with a 7-hydroxy group is subjected to Pummerer reaction conditions to obtain said 7-methylthiomethyl-paclitaxel derivative.

22. The method according to claim 20, wherein said 2'-protected paclitaxel derivative with a 7-hydroxy group is reacted with dimethyl sulfide and benzoyl peroxide to obtain said 7-methylthiomethyl-paclitaxel derivative.

23. The method according to claim 20, wherein the alkali metal or alkaline earth metal base is at least one compound selected from sodium hexamethyldisilazide (NaHMDS), potassium hexamethyldisilazide (KHMDS), lithium hexamethyldisilazide (LiHMDS), potassium diisopropylamide (KDA), lithium diisopropylamide (LDA), sodium hydride (NaH), potassium hydride (KH), lithium hydride (LiH), calcium hydride (CaH.sub.2), magnesium hydride (MgH.sub.2), and n-butyl Li.

24. The method according to claim 23, wherein said at least one compound is a hexamethyldisilazide.

25. The method according to claim 24, wherein said hexamethyldisilazide is sodium hexamethyldisilazide, and R is Na.

26. The method according to claim 20, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

27. The method according to claim 26, wherein G.sub.1 is ethoxyethyl.

28. The method according to claim 24, wherein said hexamethyldisilazide is lithium hexamethyldisilazide, and R is Li.

29. The method according to claim 28, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

30. The method according to claim 29, wherein G.sub.1 is ethoxyethyl.

31. The method according to claim 21, wherein the alkali metal or alkaline earth metal base is at least one compound selected from sodium hexamethyldisilazide (NaHMDS), potassium hexamethyldisilazide (KHMDS), lithium hexamethyldisilazide (LiHMDS), potassium diisopropylamide (KDA), lithium diisopropylamide (LDA), sodium hydride (NaH), potassium hydride (KH), lithium hydride (LiH), calcium hydride (CaH.sub.2), magnesium hydride (MgH.sub.2), and n-butyl Li.

32. The method according to claim 31, wherein said at least one compound is a hexamethyldisilazide.

33. The method according to claim 32, wherein said hexamethyldisilazide is sodium hexamethyldisilazide, and P is Na.

34. The method according to claim 33, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

35. The method according to claim 34, wherein G.sub.1 is ethoxyethyl.

36. The method according to claim 32, wherein said hexamethyldisilazide is lithium hexamethyldisilazide, and R is Li.

37. The method according to claim 36, wherein G.sub.1 is selected from methoxymethyl (MOM), .beta.-methoxyethoxymethyl (MEM), trialkylsilyl, triphenylmethyl (trityl), tert-butoxycarbonyl (t-BOC), ethoxyethyl (EE), F-MOC, and TROC.

38. The method according to claim 37, wherein G.sub.1 is ethoxyethyl.

39. A method of preparing a 7-methylthiomethyl-paclitaxel derivative, comprising: performing a metalation of a 7-methylthiomethyloxy-baccatin III derivative with an alkali metal or alkaline earth metal base, to produce a metalized 7-methylthiomethyl-baccatin III derivative of formula (A): ##STR46## wherein R is an alkali metal or alkaline earth metal; coupling the metalized 7-methylthiomethyl-baccatin III derivative of formula (A) with a .beta.-lactam, wherein said .beta.-lactam comprises a lactam of formula: ##STR47## wherein Y is oxygen; G.sub.1 is an hydroxyl protecting group; R.sub.2 " is phenyl; and R.sub.3 " is phenyl; producing a 2'-protected 7-methylthiomethyl-paclitaxel derivative; and optionally deprotecting said 2'-protected 7-methylthiomethyl-paclitaxel derivative to yield the 7-methylthiomethyl-paclitaxel derivative.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc